Isabella Cueto and Elaine Chen

BioTech

Novo to test Wegovy and other obesity drugs against alcohol-related liver disease

Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease, and, as part of that, will study if the treatments

Isabella Cueto and Elaine Chen May 14, 2024

BioTech

Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch

Chronic disease is, by its very definition, omnipresent. But changes year to year have the potential to make certain conditions into flaming-red targets for researchers

Isabella Cueto and Elaine Chen December 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Isabella Cueto and Elaine Chen

Novo to test Wegovy and other obesity drugs against alcohol-related liver disease

Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe